Healthcare
Bionic Bloom Integrated Health Welcomes Kathryn Silver, MA, RMHCI as New Art Therapy Provider
Experienced art therapist expands access to creative, trauma-informed care for adults, adolescents and families
Aug 29 · 11:00Newswire.com
6,678 press releases indexed under healthcare.
Experienced art therapist expands access to creative, trauma-informed care for adults, adolescents and families
ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit...
MIMRYLO ™ is the First and Only Hepcidin Mimetic Peptide Therapy Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera, Offering a Novel Mechanism to Maintain Hematocrit Control, Meaningfully Reduce Phlebotomy Burden, and Improve Fatigue Approval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Response During Weeks 20-32 FDA Approval Triggers $275M in Milestones, 14%-29% Royalties, with Up to an Additional $875M in Potential Future Milestones Investor call to be held Monday, August 31st at 8:30 am ET
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that it has become the first Host City Partner for the One Young World 2027 Tokyo Summit (“the Summit”), the world's largest gatherings of young leaders. - - The Summit is scheduled to take place at the Tokyo International Forum from September 28 to October 1, 2027, with more than 2,000 young leaders from over 190 countries expected to attend. Delegates will discuss global social, environmental... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359715
SkyDrive held a discussion with the Taiwan Civil Aeronautics Administration (CAA), joined by its Taiwanese business partner, 7A Drones, as well as the Industrial Technology Research Institute (ITRI), a premier research organization in Taiwan. - - Together with ITRI and 7A Drones, SkyDrive is working to establish a public-private partnership framework and introduce an eVTOL emergency medical transport model in Taiwan's Penghu Islands (*1). - - In the course of this visit, discussions were hel... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359713
FedEx Corp. (NYSE: FDX) has achieved a major milestone in its healthcare logistics journey, securing 30 IATA CEIV Pharma certifications across its global air hubs and cargo handling facilities. This accomplishment positions FedEx among the top global transportation providers with one of the industry's largest networks recognized for excellence in pharmaceutical handling. This underscores a commitment to precision and quality and is a testament to the capabilities leveraged by FedEx Life S... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359709
(PR-inside.com) NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC / ACCESS Newswire / August 28, 2026 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE), a clinical-stage biopharmaceutical company advancing therapeutic development programs through focused subsidiary companies, is pleased to announce an upsize to its previously announced non-brokered private placement offering of common shares in the capital of the Company ("CommonShares") at a price of $0.085 per Common Share (the "Private Placement"). The Company closed the first tranche of the Private Placement on August 19, 2026 (the "First Tranche") through the issuance of 24,705,880 for ..
OSAKA, Japan & CAMBRIDGE, Mass., August 28, 2026--Takeda (TSE:4502/NYSE:TAK) announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer.
Today the California Legislature took a major step toward protecting public health by passing a first-of-its-kind bill to create a certified “non-ultra-processed” food label intended to make it easier for consumers to choose less-processed foods in the grocery store. - - Assembly Bill 2244, authored by Assemblymember Jesse Gabriel (D-Encino ), would develop a state certification program for products that are not ultra-processed, or UPF. If enacted, it would create a new standardized and go... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359695
MONTRÉAL, Aug. 28, 2026 /PRNewswire/ -- Pharmacy leaders, invited from around the world, gathered in Montréal today for an international forum on advancing pharmacists' integration into primary health care, where they identified workforce readiness, sustainable funding models, supportive...
The Director-General (DG) of the World Health Organization (WHO) is hereby transmitting the report of the second meeting of the International Health Regulations (2005) ( IHR ) Emergency Committee (Committee) regarding the epidemic of Ebola disease caused by Bundibugyo virus (BVD) in the Democratic Republic of the Congo (DRC), held on Tuesday, 18 August 2026, from 12:00 to 17:00 CEST. - - The DG welcomes the Statement by the Committee, presented at the beginning of its report, and expresse... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=359686
SAN FRANCISCO, August 28, 2026--Innolitics, a medical-device software and FDA regulatory services provider, and BEACON-Neuro.AI Inc., a Washington University in St. Louis startup, today announced the partnership behind BEACONPredict, AI software for predicting malignant cerebral edema risk after acute ischemic stroke. Innolitics brought the regulatory strategy and software engineering; BEACON-Neuro.AI brought the clinical science out of Dr.